Benign Tumors


Non-neoplastic lesions

Neoplastic lesions

Mesenchymal lesions

Other lesions

Hyperplastic polyp

Adenoma

 Tubular adenoma

 Villous adenoma

 Tubulovillous adenoma

Lipoma

Endometriosis

Hamartoma

 Juvenile polyp

 Peutz-Jeghers polyp
 
Hamartoma

Pneumatosis cystoides intestinalis

Inflammatory polyps
 
Leiomyoma
 
Lymphoid polyps
 
Neuroma
   
Angioma
 

Refer to Schiedeck [36]



Adenomatous polyps make up the majority (two-thirds) of all polyps. Although only a small percentage of them are cancerous, most of all malignant polyps are adenomatous.

Serrated polyps have a malignant tendency that depends on their size and location. Small serrated polyps or so-called hyperplastic polyps of the lower colon have almost no tendency to develop malignancy. Larger serrated polyps are mostly flat (sessile) and can be found in the upper colon. They are considered precancerous [7, 8]. Polyps can be classified by origin and malignancy based on histology.

Nonspecific inflammation and/or abnormal mucosal maturation can cause non-neoplastic epithelial polyps, which do not transform into malignant lesions. Neoplastic epithelial lesions are a result of proliferative dysplasia and are premalignant.

As the name implies, mesenchymal polyps originate from connective tissue cells and are located in the submucosal or muscle layer. Some authors summarize mesenchymal lesions and other nonepithelial polyps as polypoid tumors [8].

Benign tumours of the colon and rectum (Table 22.1) are separated into four categories:



  • Non-neoplastic epithelial lesions


  • Neoplastic epithelial lesions


  • Mesenchymal lesions


  • Other lesions




22.2 Non-neoplastic Epithelial Lesions






  • Incidence increases with age.


  • Formation occurs sporadically.


22.2.1 Hyperplastic Polyps



Epidemiology

Hyperplastic polyps with a diameter less than 5 mm often occur in a pile and are ubiquitous in the entire colorectum (Fig. 22.1). They definitely have no malignant potency [4].

A80952_2_En_22_Fig1_HTML.gif



Fig. 22.1


Symptoms

The main symptom of hyperplastic polyps is prolapse.


Diagnosis

A colonoscopy is necessary to confirm a diagnosis of polyps. Multiple hyperplastic polyps should be excised and sent for histological examination to confirm their benign nature.


Therapy

Colonoscopic snaring is the therapy of choice; further treatment is not recommended [9].


22.2.2 Hamartomas



Epidemiology

Hamartomas are benign lesions consisting of both epithelial and mesenchymal components. They are classified as a benign mesenchymal lesion; the epithelial components seem to be reactive [10].


Symptoms

Hamartomas are usually asymptomatic. Obstruction and/or bleeding rarely occur.


Diagnosis

A colonoscopy is necessary to confirm the diagnosis of hamartoma. The lesion should be excised and sent for histological examination to confirm its benign nature.


Therapy

Colonoscopic snaring is the therapy of choice; further treatment is not recommended.


22.2.3 Juvenile Polyps



Epidemiology

The term juvenile polyps sums up pediatric gastrointestinal polyps that are either of hamartomatous or reactive inflammatory origin. A juvenile polyp is neither a neoplasm nor a premalignant condition.

Their incidence is higher in boys than in girls, and they are usually found in children younger than the age of 10 years. The presence of more than five juvenile polyps defines juvenile polyposis syndrome [11].


Symptoms

Polyps are usually asymptomatic. Obstruction and/or bleeding rarely occur.


Diagnosis

A colonoscopy is necessary to confirm the diagnosis of polyps. Multiple polyps should be excised and sent for histological examination. A histological distinction between a juvenile polyp and an adenomatous polyp is essential. The complete colon has to be examined endoscopically to exclude juvenile polyposis syndrome.


Therapy

Colonoscopic snaring is the therapy of choice; further treatment is not recommended.


22.2.4 Juvenile Polyposis Syndrome



Epidemiology

In contrast to single juvenile polyps, so-called juvenile polyposis syndrome, referring to the presence of more than five juvenile polyps, is associated with malignancy. The risk of patients with juvenile polyposis developing cancer of the colon before 60 years of age ranges from 20 up to 60 % [1214].

These lesions are ubiquitous in the gastrointestinal tract. The disease can be hereditary and is associated with mutations in two genes on chromosomes 10 and 18 [1517].


Symptoms

Colorectal polyps predominantly cause diffuse symptoms such as bleeding, acute abdominal pain, and diarrhea. Probably as a result of genetic dysfunction, the following concomitant extracolonic manifestations may be found:



  • Macrocephaly


  • Bony swellings


  • Cleft lip/cleft palate


  • Double renal pelvis and ureter


  • Acute glomerulonephritis


  • Undescended testicle


  • Bifid uterus and vagina


Therapy

Colonoscopic excisions should be considered if only a few polyps are found. Surgical approaches depend on the site of lesion, especially if the rectum is involved:



  • Colectomy and ileorectal anastomosis


  • Proctocolectomy and pouch


  • Proctocolectomy and ileostomy


Follow-Up

Because of the increased incidence of malignant tumors, even in other organs, careful, risk-adapted follow-up is recommended. In this case the term risk-adaption includes a full family history of cancer.


22.2.5 Peutz-Jeghers Syndrome



Epidemiology

Peutz-Jeghers syndrome is a rare, hereditary autosomal-dominant disorder with a mutation on chromosome 19. The typical age at presentation is 10–30 years. There is a signature presentation with hamartomatous polyposis of the gastrointestinal tract and melanotic pigmented spots. Melanotic pigmented spots appear in early childhood at the age of 2 years and increase in size and colour until puberty; after that they slowly fade. The location of these spots varies Notiz:

A80952_2_En_22_Fig2_HTML.gif


Fig. 22.2
(Reprinted with permission from Prof. Gabriela Möslein)




  • Lips and perioral tissue (94 %) (Fig. 22.2)


  • Hands (74 %)


  • Oral mucosa (66 %)


  • Feet (62 %)

Polyps are located all over the gastrointestinal tract but not the mouth (Fig. 22.3):

A80952_2_En_22_Fig3_HTML.gif


Fig. 22.3
(Reprinted with permission from Prof. Gabriela Möslein)




  • Small intestine (64 %)


  • Stomach (49 %)


  • Colon (64 %)


  • Rectum (32 %)


  • Esophagus, lungs, bladder, nostrils (occasionally)

Histologically, Peutz-Jeghers polyps consist of connective tissue and well-developed smooth muscle. The risk of polyps undergoing malignant transformation has been regarded as minimal, but recent studies show a lifetime risk of 85 % [4, 17]. Fifty percent of patients with Peutz-Jeghers syndrome die from cancer before the age of 60. Cancer arises in difference locations:



  • Stomach (57 %)


  • Breast (45 %)


  • Other: ovaries, cervix, lungs, pancreas, uterus, testicles


Symptoms

Typical symptoms are intestinal obstruction and bleeding [18].


Diagnosis

Case history (family history, gastrointestinal symptoms) is key. Pigmentation is a signature feature and can be found during a clinical exam. In addition, contrast enema can show multiple polyps, and gastroscopy and colonoscopy allow histological probes.


Therapy

There is no causal therapy. Endoscopic snaring is recommended since the frequency of tumors decreases with age. Surgical approaches are recommended in obstruction or intussusception that cannot be solved colonoscopically, but resections should be done restrictively [19].


22.2.6 Inflammatory Polyps



Epidemiology

Polyps may have an inflammatory origin as a result of long-lasting ulcerative colitis or Crohn’s disease of the colon. Histologically they are pseudo-polyps showing inflamed mucosa surrounded by ulcerative tissue, with no tendency for malignant transformation. Malignancy can, however, be a result of chronic ulcerative colitis or Crohn’s disease.


Symptoms

Typical symptoms are intestinal obstruction and bleeding.


Diagnosis

Polyps should be excised and send for histological examination to distinguish a diagnosis.


Therapy

Inhibition of the underlying inflammation is a basic treatment. In addition, colonoscopic snaring is recommended.


22.2.7 Lymphoid Polyps



Epidemiology

Lymphoid polyps are benign lesions and are located where piles of lymphoid follicles are present. They must be differentiated from malignant lymphomas. Histologically, lymphoid polyps comprise lymphoid tissue [4, 20].


Symptoms

Polyps are usually asymptomatic. Obstruction and/or bleeding rarely occur.


Diagnosis

Polyps should be excised colonoscopically and send for histological examination to distinguish a diagnosis.


Therapy

Colonoscopic snaring is recommended.


22.3 Neoplastic Epithelial Lesions



22.3.1 Adenomas



Epidemiology

The incidence of adenomatous polyps (adenomas) depends on age, sex, and geography. The incidence in Western countries is 7–12 %. Risk factors may be a diet low in fiber and high in fat, a positive family history of colorectal and/or gynecological cancer, atherosclerosis, nulliparity (in women), and age. Maximum incidence occurs at an age of 60–70 years.

Adenomas originate from the proliferation of glandular epithelium within the colonic or rectal mucosa. Multiple polyps can be found in the colon and rectum (5–100 lesions; familial adenomatous polyposis [FAP] >100).

Though adenomas are histologically proven benign tumors, they are a precursor to colorectal cancer [4].

Oct 30, 2017 | Posted by in ABDOMINAL MEDICINE | Comments Off on Benign Tumors

Full access? Get Clinical Tree

Get Clinical Tree app for offline access